DNA methylation, catalyzed by DNA methyltransferases (DNMTs), is the most prevalent form of epigenetic abnormality. Inhibition of DNMT3B methylation by lncRNA H19 reduces BECN1 promoter methylation, promoting cell autophagy and attenuating tamoxifen sensitivity in BC. This evidence concerns the gene DNMT3B and breast cancer.